mesalamine and cannabidiol

mesalamine has been researched along with cannabidiol in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Bar-Lev Schleider, L; Konikoff, FM; Lish, I; Naftali, T; Ringel, Y; Sklerovsky Benjaminov, F	1

Other Studies

2 other study(ies) available for mesalamine and cannabidiol

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Medical cannabis for inflammatory bowel disease: real-life experience of mode of consumption and assessment of side-effects. European journal of gastroenterology & hepatology, 2019, Volume: 31, Issue:11 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Biological Products; C-Reactive Protein; Cannabidiol; Dronabinol; Drug Administration Routes; Employment; Female; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Israel; Male; Medical Marijuana; Mesalamine; Middle Aged; Patient Reported Outcome Measures; Patient Satisfaction; Prospective Studies; Serum Albumin; Treatment Outcome; Tumor Necrosis Factor Inhibitors; Weight Gain; Young Adult	2019

Article

Year

Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.

Chemical research in toxicology, 2010, Volume: 23, Issue:1

Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010

Medical cannabis for inflammatory bowel disease: real-life experience of mode of consumption and assessment of side-effects.

European journal of gastroenterology & hepatology, 2019, Volume: 31, Issue:11

Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Biological Products; C-Reactive Protein; Cannabidiol; Dronabinol; Drug Administration Routes; Employment; Female; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Israel; Male; Medical Marijuana; Mesalamine; Middle Aged; Patient Reported Outcome Measures; Patient Satisfaction; Prospective Studies; Serum Albumin; Treatment Outcome; Tumor Necrosis Factor Inhibitors; Weight Gain; Young Adult

2019